Overall, SIRT1’s modulation may influence glioma cell survival and proliferation, and SRT2183 has potential as a therapeutic agent against glioma by inducing growth inhibition and apoptosis, primarily through the activation of ER stress pathways [47]. This evidence concerns the gene SIRT1 and central nervous system cancer.